UnitedHealth Group’s Sir Andrew Witty will take a leave of absence running Optum to “co-lead a global effort of the World Health Organization” to develop a vaccine for the Coronavirus strain ...

Optum Health expects to treat 4 million people in fully accountable care models this year, executives said Friday. UnitedHealth Group CEO Andrew Witty said on the company's fourth-quarter earnings ...

Optum Care will likely serve just under 3 million members in capitated payment arrangements by the end of this year, he said. This also represents an area for future growth, as it's just a ...

Andrew Witty, who for years was the chief executive of one of the world’s largest pharmaceutical companies GlaxoSmithKline, will be stepping in as the new chief executive of Optum come July 1.

Andrew Witty will oversee enterprise business strategy formulation and development among other duties while continuing as CEO at Optum, according to an announcement this week from Minnetonka-based ...

UnitedHealth Group’s fast-growing Optum is rolling out what it hopes will be a seamless “city-by-city” effort to make healthcare more seamless to patients, Andrew Witty said at the 2019 ...

Sir Andrew Witty is the CEO of Optum and the president of UnitedHealth Group. Richard Fleischman. By Mark Reilly – Managing Editor, Minneapolis / St. Paul Business Journal. Dec 3, 2021.

Andrew Witty — who became UnitedHealth Group’s CEO in 2021 — is stepping down from the top post due to personal reasons after years leading large health care companies. During the tail end ...

Optum CEO Andrew Witty Gets a Promotion. After joining the company 18 months ago, Witty has been named president of UnitedHealth Group. By Dan Niepow November 11, 2019. Less ...

“Next year, we will once again grow at a pace exceeding that of the broader market,” CEO Andrew Witty said on the call. Within its insurance segment, UnitedHealthcare’s profit margin ...

Former GSK chief Andrew Witty to lead UnitedHealth’s Optum unit on whatsapp (opens in a new window) Save. Sarah Neville, Global Pharmaceuticals Editor. Published March 13 2018.